The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the sixth most common cancer in the US. However, no significant changes in management have occurred since the tyrosine kinase era until the recent breakthrough with checkpoint inhibitors. Therefore, the need for more therapeutic options is paramount. Our objective was t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Pletcher, Jerred P., Bhattacharjee, Sayani, Doan, Jonathan P., Wynn, Rebecca, Sindhwani, Puneet, Nadiminty, Nagalakshmi, Petros, Firas G.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300201/
https://ncbi.nlm.nih.gov/pubmed/34307148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.681441
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars